Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data Sources and Study Subjects
2.2. Definition of Study Variables
2.3. Definition of Metabolic Syndrome
2.4. Statistical Analysis
3. Results
3.1. Comparison of Changes in Basic Characteristics of Study Subjects before and after the COVID-19 Pandemic Outbreak
3.2. Comparison of Changes in MetS Components before and after the COVID-19 Outbreak
3.3. Comparison of Changes in Metabolic Syndrome Components before and after the COVID-19 Pandemic Outbreak by Sex
3.4. Differences in Candidate Risk Factors According to Metabolic Syndrome
4. Discussion
5. Conclusions
6. Recommendation
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sanyaolu, A.; Okorie, C.; Marinkovic, A.; Patidar, R.; Younis, K.; Desai, P. Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med. 2020, 2, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Lim, S.; Lim, H.; Despres, J.P. Collateral damage of COVID-19 pandemic on nutritional quality and physical activity: Perspective from South Korea. Obesity 2020, 173, 767–770. [Google Scholar] [CrossRef] [PubMed]
- Kim, W.Y.; Kim, K.M.; Kim, Y.K.; Kum, M.S.; Kwon, H.T.; Han, M.S.; Lee, H.; Choi, E.H. Limited Benefit of Facility Isolation and the Rationale for Home Care in Children with Mild COVID-19. J. Korean Med. Sci. 2021, 36, e45. [Google Scholar] [CrossRef]
- Kim, E.S.; Kwon, Y.; Choe, Y.H.; Kim, M.J. COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. Sci. Rep. 2021, 11, 5494. [Google Scholar] [CrossRef] [PubMed]
- Kang, H.M.; Jeong, D.C.; Suh, B.K.; Ahn, M.B. The Impact of the Coronavirus Disease-2019 Pandemic on Childhood Obesity and Vitamin D Status. J. Korean Med. Sci. 2021, 36, e21. [Google Scholar] [CrossRef] [PubMed]
- Sara, A.R.; Raslan, M.; Shehata, E.M.; Sabri, N.A. Impact of Applied Protective Measures of COVID-19 on Public Health. Acta Sci. Pharm. Sci. 2021, 5, 63–72. [Google Scholar]
- Storz, M.A. The COVID-19 pandemic: An unprecedented tragedy in the battle against childhood obesity. Clin. Exp. Pediatr. 2020, 63, 477–482. [Google Scholar] [CrossRef]
- Hampl, S.E.; Hassink, S.G.; Skinner, A.D.; Armstrong, S.C.; Barlow, S.E.; Bolling, C.F.; Edwards, K.C.A.; Eneli, I.; Hamre, R.; Joseph, M.M.; et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity. Pediatrics 2023, 151, e202206040. [Google Scholar] [CrossRef]
- Ebbeling, C.B.; Pawlak, D.B.; Lugwig, D.S. Childhood obesity: Public-health crisis, common sense cure. Lancet 2002, 360, 473–482. [Google Scholar] [CrossRef]
- Nam, H.K.; Kim, H.R.; Rhie, Y.J.; Lee, K.H. Trends in the prevalence of extreme obesity among Korean children and adolescents from 2001 to 2014. J. Pediatr. Endocrinol. Metab. 2017, 30, 517–523. [Google Scholar] [CrossRef]
- Kim, J.H.; Moon, J.S. Secular Trends in Pediatric Overweight and Obesity in Korea. J. Obes. Metab. Syndr. 2020, 29, 12–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tagi, V.M.; Samvelyan, S.; Chiarelli, F. Treatment of Metabolic Syndrome in Children. Horm. Res. Paediatr. 2020, 93, 215–225. [Google Scholar] [CrossRef] [PubMed]
- Kwon, J.Y.; Song, S.W.; Kim, H.N.; Kang, S.G. Changes in Body Mass Index and Prevalence of Metabolic Syndrome during COVID-19 Lockdown Period. Korean J. Fam. Pract. 2021, 11, 304–311. [Google Scholar] [CrossRef]
- Woo, S.R.; Yang, H.N.; Kim, Y.M.; Lim, H.J.; Song, H.J.; Park, K.H. Sedentary Time and Fast-Food Consumption Associated with Weight Gain During COVID-19 Lockdown in Children and Adolescents with Overweight or Obesity. J. Korean Med. Sci. 2022, 37, e103. [Google Scholar] [CrossRef] [PubMed]
- Kweon, S.; Kim, Y.; Jang, M.J.; Kim, Y.; Kim, K.; Choi, S.; Chun, C.; Khang, Y.-H.; Oh, K. Data resource profile: The Korea National Health and Nutrition Examination Survey (KNHANES). Int. J. Epidemiol. 2014, 43, 69–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.H.; Yun, S.; Hwang, S.S.; Shim, J.O.; Chae, H.W.; Lee, Y.J.; Lee, J.H.; Kim, S.C.; Lim, D.; Yang, S.W.; et al. The 2017 Korean National Growth Charts for children and adolescents: Development, improvement, and prospects. Korean J. Pediatr. 2018, 61, 135–149. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Guidelines on Physical Activity and Sedentary Behaviour; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Chae, J.; Seo, M.Y.; Kim, S.H.; Park, M.J. Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018. Diabetes Metab. J. 2021, 45, 880–889. [Google Scholar] [CrossRef]
- Dutra, L.M.; Glantz, S.A. Thirty-day smoking in adolescence is a strong predictor of smoking in young adulthood. Prev. Med. 2018, 109, 17–21. [Google Scholar] [CrossRef]
- Sim, E.; Sohn, W.; Choi, E.S.; Noh, H. Sugar-sweetened beverage consumption frequency in Korean adolescents: Based on the 2015 Youth Risk Behavior Web-Based Survey. Int. Dent. J. 2019, 69, 376–382. [Google Scholar] [CrossRef]
- The Korean Nutrition Society. Dietary Reference Intakes for Koreans 2015, 1st ed.; The Korean nutrition Society: Seoul, Republic of Korea, 2016; pp. 25–183. [Google Scholar]
- Korean Center for Disease Control and Prevention. 2007 Korean Children and Adolescent Growth Standard. 2007. Available online: http://www.cdc.go.kr/CDC/cms/content/mobile/35/1235_view.html (accessed on 14 February 2022).
- Eisenmann, J.C. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc. Diabetol. 2008, 7, 17. [Google Scholar] [CrossRef] [Green Version]
- Kelly, A.S.; Barlow, S.E.; Rao, G.; Inge, T.H.; Hayman, L.L.; Steinberger, J.; Urbina, E.M.; Ewing, L.J.; Daniels, S.R. Severe obesity in children and adolescents: Identification, associated health risks, and treatment approaches: A scientific statement from the American Heart Association. Circulation 2013, 128, 1689–1712. [Google Scholar] [CrossRef] [PubMed]
- Yi, D.Y.; Kim, S.C.; Lee, J.H.; Lee, E.H.; Kim, J.Y.; Kim, Y.J.; Kang, K.S.; Hong, J.; Shim, J.O.; Lee, Y.; et al. Clinical practice guideline for the diagnosis and treatment of pediatric obesity: Recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and Nutrition. Korean J. Pediatr. 2019, 62, 3–21. [Google Scholar] [CrossRef] [PubMed]
- Cho, W.K.; Han, K.; Ahn, M.B.; Park, Y.G.; Jung, M.H.; Suh, B.K.; Park, Y.G. Metabolic risk factors in Korean adolescents with severe obesity: Results from the Korea National Health and Nutrition Examination Surveys (K-NHANES) 2007–2014. Diabetes Res. Clin. Pract. 2018, 138, 169–176. [Google Scholar] [CrossRef] [PubMed]
- Huh, J.H.; Kang, D.R.; Jang, J.-Y.; Shin, J.-H.; Kim, J.Y.; Choi, S.; Cho, E.J.; Park, J.-S.; Sohn, I.S.; Jo, S.-H.; et al. Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018). Atherosclerosis 2018, 277, 47–52. [Google Scholar] [CrossRef] [PubMed]
- Kang, S.Y.; Seo, M.Y.; Kim, S.H.; Park, M.J. Changes in lifestyle and obesity during the COVID-19 pandemic in Korean adolescents: Based on the Korea Youth Risk Behavior Survey 2019 and 2020. Ann. Pediatr. Endocrinol. Metab. 2022, 27, 281–288. [Google Scholar] [CrossRef]
- Kaditis, A.G.; Ohler, A.; Gileles-Hillel, A.; Choshen-Hillel, S.; Gozal, D.; Bruni, O.; Aydinoz, S.; Cortese, R.; Kheirandish-Gozal, L. Effects of the COVID-19 lockdown on sleep duration in children and adolescents: A survey across different continents. Pediatr Pulmonol. 2021, 56, 2265–2273. [Google Scholar] [CrossRef]
- Dighe, A.; Cattarino, L.; Cuomo-Dannenburg, G.; Skarp, J.; Imai, N.; Bhatia, S.; Gaythorpe, K.A.M.; Ainslie, K.E.C.; Baguelin, M.; Bhatt, S.; et al. Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020, 18, 321. [Google Scholar] [CrossRef]
- Kim, J.H.; Park, Y.S. Low muscle mass is associated with metabolic syndrome in Korean adolescents: The Korea National Health and Nutrition Examination Survey 2009–2011. Nutr. Res. 2016, 36, 1423–1428. [Google Scholar] [CrossRef]
- Huh, J.Y.; Kang, D.R.; Kim, J.Y.; Koh, K.W. Metabolic Syndrome Fact Sheet 2021: Executive Report. Cardiometab. Syndr. J. 2021, 1, 125–134. [Google Scholar] [CrossRef]
- Kim, J.H.; Lim, J.S. Prevalence Trends of Metabolic Syndrome among Korean Children and Adolescents from a Population-Based Cross-Sectional Survey. Life 2022, 12, 1404. [Google Scholar] [CrossRef]
- Kim, M.S.; Kim, J.H. Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: Data from the Korea National Health and Nutrition Examination Survey 2007–2018. Ann. Pediatr. Endocrinol. Metab. 2022, 27, 289–299. [Google Scholar] [CrossRef]
- Adullah, A.; Stoelwinder, J.; Shortreed, S.; Wolfe, R.; Stevenson, C.; Walls, H.; Courten, M.D.; Peeters, A. The duration of obesity and the risk of type 2 diabetes. Public Health Nutr. 2011, 14, 119–126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, Y.S.; Kang, S.H.; Jang, S.I.; Park, E.C. Association between lifestyle factors and the risk of metabolic syndrome in the South Krea. Sci. Rep. 2022, 12, 13356. [Google Scholar] [CrossRef] [PubMed]
- Katzmarzyk, P.T.; Broyles, S.T.; Champagne, C.M.; Chaput, J.-P.; Fogelholm, M.; Hu, G.; Kuriyan, R.; Kurpad, A.; Lambert, E.V.; Maia, J.; et al. Relationship between Soft Drink Consumption and Obesity in 9–11 Years Old Children in a Multi-National Study. Nutrients 2016, 8, 770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, H.J. Influences of Sarcopenic and Non-sarcopenic Obesity on the Components of Metabolic Syndrome in Adolescents. J. Korean Biol. Nur. Sci. 2017, 19, 266–275. [Google Scholar] [CrossRef]
- Alpcan, A.; Tursun, S.; Kandur, Y. Vitamin D levels in children with COVID-19: A report from Turkey. Epidemiol. Infect. 2021, 149, e180. [Google Scholar] [CrossRef] [PubMed]
- Szarpark, L.; Rafique, Z.; Gasecka, A.; Chirico, F.; Gawel, W.; Hernik, J.; Kaminska, H.; Filipiak, K.J.; Jaguszewski, M.J.; Szarpak, L. A systematic review and meta-analysis of effect of vit amin D levels on the incidence of COVID-19. Cardiol. J. 2021, 28, 647–654. [Google Scholar] [CrossRef]
Variables | Children Aged 2–9 Years | Children Aged 10–18 Years | ||||
---|---|---|---|---|---|---|
Before (2019) | After (2020) | p-Value | Before (2019) | After (2020) | p-Value | |
Age (years) | 5.6 (5.41–5.79) | 5.78 (5.56–6.01) | 0.21 | 14.16 (13.93–14.39) | 14.07 (13.82–14.32) | 0.6 |
Sex | ||||||
Boys | 357 (51.92%) | 284 (52.22%) | 0.92 | 359 (52.22%) | 326 (53.41%) | 0.71 |
Girls | 345 (48.08%) | 259 (47.78%) | 310 (47.78%) | 255 (46.59%) | ||
Household incomes | ||||||
Q1 (low) | 48 (6.36%) | 33 (5.98%) | 0.54 | 66 (10.68%) | 44 (7.14%) | 0.15 |
Q2 | 224 (32.63%) | 168 (29.76%) | 199 (29.1%) | 159 (26.88%) | ||
Q3 | 248 (35.01%) | 178 (32.5%) | 196 (29.61%) | 217 (37.85%) | ||
Q4 (high) | 182 (26%) | 164 (31.77%) | 206 (30.61%) | 160 (28.12%) | ||
Paternal education | ||||||
Less than high school graduate | 147 (29.54%) | 109 (25.99%) | 0.44 | 177 (38.76%) | 159 (41.09%) | 0.64 |
College graduate or higher | 347 (70.46%) | 278 (74.01%) | 269 (61.24%) | 212 (58.91%) | ||
Maternal education | ||||||
Less than high school graduate | 163 (25.7%) | 148 (30.32%) | 0.27 | 253 (42.54%) | 222 (43.99%) | 0.75 |
College graduate or higher | 467 (74.3%) | 336 (69.68%) | 350 (57.46%) | 273 (56.01%) | ||
Body mass index (kg/m2) | 16.53 (16.31–16.75) | 17.1 (16.8–17.4) | 0.00 | 21.25 (20.78–21.72) | 21.41 (20.94–21.87) | 0.64 |
Regular physical activity (age ≥12 years) a | NA | NA | NA | 14 (3.36%) | 13 (2.45%) | 0.54 |
Regular strength training (age ≥12 years) b | NA | NA | NA | 133 (29.12%) | 137 (31.6%) | 0.49 |
Sedentary time (h, age ≥12 years) | NA | NA | NA | 11.32 (11.06–11.57) | 11.19 (10.89–11.49) | 0.52 |
Recognizing stress (age ≥12 years) | NA | NA | NA | 113 (23.08%) | 107 (26.21%) | 0.37 |
Average sleep time per day of the weekday (h, age ≥12 years) | NA | NA | NA | 6.87 (6.74–7) | 6.82 (6.68–6.97) | 0.61 |
Soft-drink intake c | ||||||
<3 times/week | 302 (82.6%) | 192 (75.77%) | 0.08 | 346 (58.09%) | 252 (57.68%) | 0.91 |
≥3 times/week | 65 (17.4%) | 58 (24.23%) | 239 (41.91%) | 190 (42.32%) | ||
Sports-drink intake c | ||||||
<3 times/week | 358 (97.58%) | 234 (93.37%) | 0.03 | 479 (81.4%) | 354 (80.43%) | 0.75 |
≥3 times/week | 9 (2.42%) | 16 (6.63%) | 106 (18.6%) | 88 (19.57%) | ||
Smoking (≥12 years) | NA | NA | NA | 15 (2.72%) | 18 (3.33%) | 0.61 |
Nutritional factor | ||||||
Dietary supplement use | 447 (66.52%) | 338 (72.36%) | 0.18 | 255 (41.77%) | 200 (44.59%) | 0.46 |
Total energy intake | 1528.21 (1473.51–1582.91) | 1537.11 (1476.05–1598.18) | 0.84 | 2016.15 (1943.83–2088.46) | 1910.08 (1831.89–1988.27) | 0.05 |
Excess calorie intake | 141 (20.71%) | 102 (21.7%) | 0.72 | 136 (24.67%) | 92 (22.89%) | 0.54 |
% of energy from carbohydrates | 60.57 (59.76–61.39) | 60.38 (59.44–61.31) | 0.76 | 59.01 (58.08–59.94) | 58.08 (56.98–59.18) | 0.21 |
Carbohydrate > 65% of total energy | 194 (30.34%) | 135 (29.72%) | 0.85 | 134 (22.83%) | 105 (23.4%) | 0.84 |
% of energy from fat | 24.79 (24.13–25.46) | 24.56 (23.72–25.4) | 0.67 | 24.97 (24.13–25.81) | 25.74 (24.86–26.62) | 0.21 |
Fat intake > 30% of total energy | 167 (23.49%) | 99 (20.41%) | 0.31 | 139 (24.01%) | 117 (25.93%) | 0.54 |
Metabolic Syndrome Components | 10–18 Years | ||
---|---|---|---|
Before (2019) | After (2020) | p-Value | |
Waist circumference (cm) | 71.9 (70.73–73.07) | 72.41 (71.18–73.63) | 0.56 |
Elevated WC (≥90th) | 83 (12.59%) | 97 (16.35%) | 0.14 |
Systolic BP (mmHg) a | 108.71 (107.59–109.82) | 109.28 (107.98–110.58) | 0.51 |
Diastolic BP (mmHg) a | 66.78 (65.82–67.73) | 68.56 (67.43–69.69) | 0.02 |
Elevated BP (≥90th) b | 11 (1.69%) | 16 (2.86%) | 0.29 |
Fasting Blood Glucose (mg/dL) | 92.46 (91.69–93.24) | 92.31 (91.14–93.47) | 0.83 |
Elevated FBG (≥100 mg/dL) | 94 (13.67%) | 73 (12.13%) | 0.49 |
Triglyceride (mg/dL) c | 75.52 (72.08–79.12) | 83.97 (79.72–88.45) | 0.00 |
Elevated TG (≥110 mg/dL) | 141 (24.2%) | 152 (27.04%) | 0.38 |
HDL-c (mg/dL) | 52.62 (51.61–53.63) | 51.42 (50.43–52.4) | 0.01 |
Low HDL (<40 mg/dL) | 46 (8.53%) | 51 (10.19%) | 0.39 |
cMetS score | 0.03 (−0.30–0.36) | 0.65 (0.29–1.01) | 0.01 |
MetS | 24 (3.79%) | 38 (7.79%) | 0.01 |
Metabolic Syndrome Components | 10–18 Years | |||||
---|---|---|---|---|---|---|
Boys | Girls | |||||
2019 | 2020 | p-Value | 2019 | 2020 | p-Value | |
Waist circumference (cm, age ≥6 years) | 75.03 (73.61–76.45) | 76.27 (74.93–77.6) | 0.22 | 68.47 (67.03–69.91) | 67.96 (66.47–69.44) | 0.63 |
Elevated WC (≥90th) | 47 (12.52%) | 63 (19.83%) | 0.02 | 36 (12.66%) | 34 (12.33%) | 0.92 |
Systolic BP (mmHg) | 111.92 (110.60–113.24) | 111.83 (110.13–113.53) | 0.94 | 105.2 (103.91–106.49) | 106.12 (104.79–107.45) | 0.34 |
Diastolic BP (mmHg) | 67.57 (66.40–68.74) | 68.78 (67.44–70.11) | 0.19 | 65.91 (64.59–67.23) | 68.29 (66.87–69.7) | 0.02 |
Elevated BP (≥90th) | 6 (2.01%) | 12 (3.9%) | 0.21 | 5 (1.34%) | 4 (1.57%) | 0.85 |
Fasting Blood Glucose (mg/dL) | 92.84 | 92.96 | 0.88 | 92.05 | 91.56 | 0.68 |
(91.87–93.82) | (91.91–94.02) | (90.92–93.19) | (89.62–93.51) | |||
Elevated FBG (≥100 mg/dL) | 51 (13.87%) | 50 (15.19%) | 0.68 | 43 (13.46%) | 23 (8.68%) | 0.08 |
Triglyceride (mg/dL) c | 76.08 (71.62–80.81) | 80.63 (75.05–86.63) | 0.23 | 74.92 (70.29–79.85) | 87.9 (82.88–93.23) | 0.00 |
Elevated TG (≥110 mg/dL) | 78 (25.10%) | 83 (27.2%) | 0.63 | 63 (23.25%) | 69 (26.87%) | 0.39 |
HDL-c (mg/dL) | 50.8 (49.60–52.00) | 50.35 (49.11–51.6) | 0.62 | 54.57 (53.01–56.13) | 52.61 (51.16–54.07) | 0.07 |
Low HDL-c (<40 mg/dL) | 32 (11.58%) | 35 (14.13%) | 0.41 | 14 (5.27%) | 16 (5.75%) | 0.83 |
MetS | 17 (4.58%) | 25 (9.47%) | 0.02 | 7 (2.96%) | 13 (5.74%) | 0.2 |
Before COVID-19 Outbreak (2019) | After COVID-19 Outbreak (2020) | |||||
---|---|---|---|---|---|---|
Normal | MetS | p Value | Normal | MetS | p Value | |
Age | 15.27 | 15.2 | 0.87 | 15.12 | 15.11 | 0.98 |
(15.1–15.45) | (14.25–16.14) | (14.93–15.32) | (14.21–16.01) | |||
Boys | 226 (52.27%) | 13 (61.57%) | 0.45 | 201(54.06%) | 22 (67.59%) | 0.15 |
Household incomes | ||||||
Q1 (low) | 39 (10.6%) | 3 (19.43%) | 0.6 | 23 (5.76%) | 3 (9.28%) | 0.83 |
Q2 | 127 (28.08%) | 4 (30.3%) | 99 (27.78%) | 6 (21.47%) | ||
Q3 | 128 (30.19%) | 7 (32.76%) | 133(38.65%) | 16 (40.46%) | ||
Q4 (high) | 141 (31.12%) | 5 (17.51%) | 98 (27.81%) | 8 (28.8%) | ||
Paternal education | ||||||
Less than high school graduate | 111 (36.74%) | 10 (95.97%) | 0.00 | 105(42.83%) | 12 (57.33%) | 0.26 |
College graduate or higher | 176 (63.26%) | 1 (4.03%) | 133(57.17%) | 7 (42.67%) | ||
Maternal education | ||||||
Less than high school graduate | 176 (43.92%) | 9 (58.4%) | 0.38 | 149(45.97%) | 13 (48.37%) | 0.84 |
College graduate or higher | 220 (56.08%) | 6 (41.6%) | 152(54.03%) | 14 (51.63%) | ||
Regular physical activity | 12 (3.33%) | 1 (3.34%) | 0.99 | 12 (2.7%) | 0 (0.00%) | NA |
(age ≥12 years) | ||||||
Regular strength training | 120 (30.08%) | 6 (25.11%) | 0.63 | 112 (30.7%) | 10 (30.69%) | 0.99 |
(age ≥12 years) | ||||||
Sedentary time | 11.3 | 11.73 | 0.42 | 11.25 | 10.81 | 0.34 |
(hours, age ≥12 years) | (11.03–11.57) | (10.68–12.78) | (10.9–11.6) | (9.96–11.67) | ||
Recognizing stress | 96 (21.47%) | 6 (31.79%) | 0.29 | 90 (26.54%) | 5 (14.14%) | 0.15 |
(age ≥12 years) | ||||||
Average sleep time per day | 0.72 | 6.75 | 7.02 | 0.32 | ||
(h, age ≥12 years) | 6.85 | 7.04 | (6.58–6.92) | (6.52–7.53) | ||
6.71–6.99) | (6.03–8.06) | |||||
Soft-drink intake | ||||||
<3 times/week | 210 (56.36%) | 4 (30%) | 0.07 | 144 (53.72%) | 11 (51.22%) | 0.82 |
≥3 times/week | 162 (43.64%) | 13 (70%) | 131 (46.28%) | 10 (48.78%) | ||
Sports-drink intake | ||||||
<3 times/week | 296 (78.71%) | 14 (86.05%) | 0.55 | 208 (77.33%) | 12 (53.57%) | 0.01 |
≥3 times/week | 76 (21.29%) | 3 (13.95%) | 67 (22.67%) | 9 (46.44%) | ||
Smoking | 15 (3.95%) | 0 (0.0%) | NA | 16 (4.82%) | 0.00% | NA |
Nutritional factor | ||||||
Dietary supplement use | 151 (39.49%) | 2 (13.55%) | 0.05 | 101 (37.52%) | 10 (46.77%) | 0.42 |
Total energy intake | 2037.5 (1942.68–2132.32) | 2169.4 (1835.98–2502.81) | 0.44 | 1941.36 (1842.46–2040.26) | 2131.52 (1762.94–2500.11) | 0.32 |
Excess calorie intake | 88 (24.66%) | 6 (42.08%) | 0.18 | 62 (24.71%) | 5 (27.6%) | 0.78 |
% of energy from | 58.69 | 60.16 | 0.53 | 58.21 | 61.31 | 0.24 |
carbohydrates | (57.57–59.8) | (55.64–64.67) | (56.85–59.57) | (56.21–66.42) | ||
Carbohydrate >65% of total energy | 79 (20.64%) | 7 (47.61%) | 0.03 | 75 (25.83%) | 7 (38.53%) | 0.25 |
% of energy from fat | 25.21 | 23.73 | 0.55 | 25.73 | 22 | 0.05 |
(24.2–26.21) | (19–28.45) | (24.56–26.9) | (18.22–25.77) | |||
Fat intake > 30% of total energy | 89 (24.12%) | 5 (25.31%) | 0.92 | 75 (26.19%) | 5 (16.57%) | 0.32 |
Before COVID-19 Outbreak (2019) | After COVID-19 Outbreak (2020) | |||||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | p-Value | AOR (95% CI) | p-Value | OR (95% CI) | p-Value | AOR (95% CI) | p-Value | |
Girls | 0.68 (0.26–1.83) | 0.45 | 0.45 (0.07–2.77) | 0.39 | 0.56 (0.26–1.24) | 0.15 | 0.82 (0.18–3.86) | 0.80 |
Age | 0.98 (0.78–1.24) | 0.87 | 1.23 (0.71–2.13) | 0.46 | 1 (0.8–1.25) | 0.98 | 1.21 (0.8–1.82) | 0.37 |
Total energy intake (per 100 kcal) | 1.02 (0.97–1.07) | 0.43 | 1.02 (0.96–1.09) | 0.46 | 1.03 (0.98–1.09) | 0.29 | 1.02 (0.95–1.1) | 0.52 |
Paternal education ≥College graduate or higher | 0.02 (0–0.22) | 0.00 | 0.03 (0–0.27) | 0.00 | 0.56 (0.2–1.55) | 0.26 | 0.54 (0.17–1.78) | 0.31 |
Soft-drink intake ≥3 times/week | 3.01 (0.85–10.71) | 0.09 | 1.73 (0.33–9.1) | 0.52 | 1.11 (0.46–2.64) | 0.82 | 0.48 (0.17–1.39) | 0.18 |
Carbohydrate >65 % of total energy | 3.5 (1.11–11.01) | 0.03 | 7.04 (1.29–38.43) | 0.02 | 1.8 (0.65–4.95) | 0.26 | 3.81 (1.03–14.11) | 0.04 |
Dietary Supplement (yes vs. no) | 0.24 (0.05–1.15) | 0.07 | 0.38 (0.04–3.65) | 0.40 | 1.46 (0.58–3.7) | 0.42 | 2.17 (0.64–7.28) | 0.21 |
Sports-drink intake ≥3 times/week | 0.6 (0.11–3.22) | 0.55 | 0.31 (0.03–3.13) | 0.32 | 2.96 (1.25–7) | 0.01 | 5.9 (1.4–24.87) | 0.02 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Choi, J.E.; Lee, H.A.; Park, S.W.; Lee, J.W.; Lee, J.H.; Park, H.; Kim, H.S. Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES. Children 2023, 10, 1105. https://doi.org/10.3390/children10071105
Choi JE, Lee HA, Park SW, Lee JW, Lee JH, Park H, Kim HS. Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES. Children. 2023; 10(7):1105. https://doi.org/10.3390/children10071105
Chicago/Turabian StyleChoi, Jung Eun, Hye Ah Lee, Sung Won Park, Jung Won Lee, Ji Hyen Lee, Hyesook Park, and Hae Soon Kim. 2023. "Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES" Children 10, no. 7: 1105. https://doi.org/10.3390/children10071105
APA StyleChoi, J. E., Lee, H. A., Park, S. W., Lee, J. W., Lee, J. H., Park, H., & Kim, H. S. (2023). Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES. Children, 10(7), 1105. https://doi.org/10.3390/children10071105